4.7 Review

Bacteriophage and Bacterial Susceptibility, Resistance, and Tolerance to Antibiotics

期刊

PHARMACEUTICS
卷 14, 期 7, 页码 -

出版社

MDPI
DOI: 10.3390/pharmaceutics14071425

关键词

bacteriophage; antibiotics resistance; horizontal gene transfer; mobile gene elements; phage antibiotics synergy

资金

  1. Cystic Fibrosis Foundation (CFF)
  2. CFF [002572CF221]
  3. Stanford MCHRI
  4. CFF Harry Shwachman Award [BURGEN20Q0]
  5. Stanford SPARK
  6. Emerson Collective
  7. [R01HL148184-01]
  8. [R01AI12492093]
  9. [R01DC019965]
  10. [K24AI16671801A1]
  11. [R21GM147838]

向作者/读者索取更多资源

Bacteriophages can have complex effects on bacterial responses to antibiotics, promoting susceptibility to antibiotics or contributing to antimicrobial resistance and tolerance. Some bacteriophages facilitate the transfer of antibiotic resistance genes between bacteria, while chronic infection by filamentous phages can promote bacterial tolerance and hinder the effectiveness of antibiotics.
Bacteriophages, viruses that infect and replicate within bacteria, impact bacterial responses to antibiotics in complex ways. Recent studies using lytic bacteriophages to treat bacterial infections (phage therapy) demonstrate that phages can promote susceptibility to chemical antibiotics and that phage/antibiotic synergy is possible. However, both lytic and lysogenic bacteriophages can contribute to antimicrobial resistance. In particular, some phages mediate the horizontal transfer of antibiotic resistance genes between bacteria via transduction and other mechanisms. In addition, chronic infection filamentous phages can promote antimicrobial tolerance, the ability of bacteria to persist in the face of antibiotics. In particular, filamentous phages serve as structural elements in bacterial biofilms and prevent the penetration of antibiotics. Over time, these contributions to antibiotic tolerance favor the selection of resistance clones. Here, we review recent insights into bacteriophage contributions to antibiotic susceptibility, resistance, and tolerance. We discuss the mechanisms involved in these effects and address their impact on bacterial fitness.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Hyaluronan synthesis inhibition impairs antigen presentation and delays transplantation rejection

Payton L. Marshall, Nadine Nagy, Gernot Kaber, Graham L. Barlow, Amrit Ramesh, Bryan J. Xie, Miles H. Linde, Naomi L. Haddock, Colin A. Lester, Quynh-Lam Tran, Christiaan R. de Vries, Aviv Hargil, Andrey V. Malkovskiy, Irina Gurevich, Hunter A. Martinez, Hedwich F. Kuipers, Koshika Yadava, Xiangyue Zhang, Stephen P. Evanko, John A. Gebe, Xi Wang, Robert B. Vernon, Carol de la Motte, Thomas N. Wight, Edgar G. Engleman, Sheri M. Krams, Everett H. Meyer, Paul L. Bollyky

Summary: Treatment with 4-methylumbelliferone (4MU) reduces pericellular hyaluronan, disrupts interactions between DC and T-cells, and inhibits T-cell proliferation. 4MU can delay rejection of allogeneic pancreatic islet and cardiac transplants, as well as suppress allogeneic T-cell activation.

MATRIX BIOLOGY (2021)

Article Multidisciplinary Sciences

Leishmania donovani infection suppresses Allograft Inflammatory Factor-1 in monocytes and macrophages to inhibit inflammatory responses

Ricardo Louzada da Silva, Diana M. Elizondo, Nailah Z. D. Brandy, Naomi L. Haddock, Thomas A. Boddie, Lais Lima de Oliveira, Amelia Ribeiro de Jesus, Roque Pacheco de Almeida, Tatiana Rodrigues de Moura, Michael W. Lipscomb

Summary: The study revealed that Leishmania donovani inhibits AIF1 expression in macrophages to block pro-inflammatory responses during infection, leading to increased parasite load. Ectopic overexpression of AIF1 in macrophages provided protection from infection, while inhibiting AIF1 expression in bone marrow cells or monocytes impaired differentiation into functional macrophages. This highlights AIF1 as a critical regulatory component in governing monocyte and macrophage immune functions during parasitic infections and demonstrates how the parasite can suppress this gene as an immune evasion tactic.

SCIENTIFIC REPORTS (2021)

Review Virology

The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies

Dan Liu, Jonas D. Van Belleghem, Christiaan R. de Vries, Elizabeth Burgener, Qingquan Chen, Robert Manasherob, Jenny R. Aronson, Derek F. Amanatullah, Pranita D. Tamma, Gina A. Suh

Summary: Phage therapy has garnered renewed interest due to increasing rates of antibiotic resistant bacteria infections. Safety and toxicity data associated with phage therapy in animals and humans have been systematically reviewed from English language publications between 2008-2021. While some adverse events were found in relation to phage therapy, serious events were extremely rare, highlighting the need for structured safety and tolerability endpoints in the therapeutic use of phages. Comprehensive and standardized reporting of potential toxicities associated with phage therapy has generally been lacking in published literature.

VIRUSES-BASEL (2021)

Article Microbiology

Filamentous Bacteriophages and the Competitive Interaction between Pseudomonas aeruginosa Strains under Antibiotic Treatment: a Modeling Study

Julie D. Pourtois, Michael J. Kratochvil, Qingquan Chen, Naomi L. Haddock, Elizabeth B. Burgener, Giulio A. De Leo, Paul L. Bollyky

Summary: A mathematical model was used to study the competition between Pf+ and Pf- strains of Pseudomonas aeruginosa in different environments, revealing that the benefits of phage production may not always outweigh the metabolic cost for bacterial fitness. Frequent administration of intermediate doses of antibiotics can favor Pf+ strains over Pf-, suggesting potential treatment strategies for combating antibiotic tolerance.

MSYSTEMS (2021)

Article Medicine, Research & Experimental

Biochemical, biophysical, and immunological characterization of respiratory secretions in severe SARS-CoV-2 infections

Michael J. Kratochvil, Gernot Kaber, Sally Demirdjian, Pamela C. Cai, Elizabeth B. Burgener, Nadine Nagy, Graham L. Barlow, Medeea Popescu, Mark R. Nicolls, Michael G. Ozawa, Donald P. Regula, Ana E. Pacheco-Navarro, Samuel Yang, Vinicio A. de Jesus Perez, Harry Karmouty-Quintana, Andrew M. Peters, Bihong Zhao, Maximilian L. Buja, Pamela Y. Johnson, Robert B. Vernon, Thomas N. Wight, Carlos E. Milla, Angela J. Rogers, Andrew J. Spakowitz, Sarah C. Heilshorn, Paul L. Bollyky

Summary: This study characterized the composition and physical properties of respiratory secretions in COVID-19 patients, revealing elevated levels of solids and proteins, similar to those seen in cystic fibrosis. DNA and hyaluronan were major components of COVID-19 secretions and were also abundant in lung tissues. The rheological behaviors of COVID-19 secretions were heterogeneous, and increased HA and DNA were associated with enhanced inflammatory burden. Decreased type I interferon and increased inflammatory cytokines were also observed.

JCI INSIGHT (2022)

Review Biochemistry & Molecular Biology

Hyaluronan in the pathogenesis of acute and post-acute COVID-19 infection

Henry W. Barnes, Sally Demirdjian, Naomi L. Haddock, Gernot Kaber, Hunter A. Martinez, Nadine Nagy, Harry Karmouty-Quintana, Paul L. Bollyky

Summary: This review focuses on the role of hyaluronan (HA) in COVID-19 pathogenesis. It discusses the roles of HA in inflammation and immunity, in COVID-19 acute respiratory distress syndrome (ARDS), in post-acute SARS-CoV-2 infection (PASC) and COVID-associated fibrosis, and potential therapeutics targeting HA such as the repurposed drug hymecromone.

MATRIX BIOLOGY (2023)

Article Oncology

Reprogramming Cancer into Antigen- Presenting Cells as a Novel Immunotherapy

Miles H. Linde, Amy C. Fan, Thomas Koehnke, Aaron C. Trotman-Grant, Sarah F. Gurev, Paul Phan, Feifei Zhao, Naomi L. Haddock, Kevin A. Nuno, Eric J. Gars, Melissa Stafford, Payton L. Marshall, Christopher G. Dove, Ian L. Linde, Niklas Landberg, Lindsay P. Miller, Robbie G. Majzner, Tian Yi Zhang, Ravindra Majeti

Summary: Therapeutic cancer vaccination aims to activate tumor-reactive T cells for recognizing tumor-associated antigens (TAA) and eliminating malignant cells. The study proposes a cancer vaccination approach using myeloid-lineage reprogramming to convert cancer cells into tumor-reprogrammed antigen-presenting cells (TR-APC). The results demonstrate the effectiveness of TR-APCs in inducing clonal expansion of cancer-specific T cells, establishing immune memory, and promoting leukemia eradication.

CANCER DISCOVERY (2023)

Article Microbiology

Phage diversity in cell-free DNA identifies bacterial pathogens in human sepsis cases

Naomi L. Haddock, Layla J. Barkal, Nikhil Ram-Mohan, Gernot Kaber, Charles Y. Chiu, Ami S. Bhatt, Samuel Yang, Paul L. Bollyky

Summary: This study found that bacterial infections release bacteriophage DNA fragments in plasma, which can be used to identify the types and strains of pathogenic bacteria. Additionally, phage sequences can differentiate between pathogenic and contaminant strains of bacterial species such as Escherichia coli and Staphylococcus aureus. Therefore, phage DNA in plasma is of great importance in studying bacterial infections.

NATURE MICROBIOLOGY (2023)

Article Microbiology

Bacteriophage populations mirror those of bacterial pathogens at sites of infection

N. L. Haddock, L. J. Barkal, P. L. Bollyky

Summary: Bacteriophages are abundant at sites of bacterial colonization, but their ecology at sites of active infection remains unclear. In this study, we investigated bacteriophage populations in cell-free DNA collected from infection sites and found that phages reflect the relative abundance of their bacterial hosts at these sites. These findings may have implications for future investigative and diagnostic approaches utilizing phages and bacterial cell-free DNA.

MSYSTEMS (2023)

Article Cell Biology

Filamentous bacteriophage delays healing of Pseudomonas-infected wounds

Michelle S. Bach, Christiaan R. de Vries, Arya Khosravi, Johanna M. Sweere, Medeea C. Popescu, Qingquan Chen, Sally Demirdjian, Aviv Hargil, Jonas D. Van Belleghem, Gernot Kaber, Maryam Hajfathalian, Elizabeth B. Burgener, Dan Liu, Quynh-Lam Tran, Tejas Dharmaraj, Maria Birukova, Vivekananda Sunkari, Swathi Balaji, Nandini Ghosh, Shomita S. Mathew-Steiner, Mohamed S. El Masry, Sundeep G. Keswani, Niaz Banaei, Laurence Nedelec, Chandan K. Sen, Venita Chandra, Patrick R. Secor, Gina A. Suh, Paul L. Bollyky

Summary: This study reveals that a bacteriophage called Pf, produced by Pseudomonas aeruginosa, delays healing of chronic wounds by inhibiting the migration of keratinocytes, which is essential for wound closure. The presence of Pf-positive strains of Pseudomonas aeruginosa in chronic wounds is associated with a higher likelihood of wound progression. These findings suggest that Pf may serve as a biomarker and potential therapeutic target for chronic wounds.

CELL REPORTS MEDICINE (2022)

Article Medicine, Research & Experimental

Oral hymecromone decreases hyaluronan in human study participants

Joelle Rosser, Nadine Nagy, Riya Goel, Gernot Kaber, Sally Demirdjian, Jamie Saxena, Jennifer B. Bollyky, Adam R. Frymoyer, Ana E. Pacheco-Navarro, Elizabeth B. Burgener, Jayakumar Rajadas, Zhe Wang, Olga Arbach, Colleen E. Dunn, Anissa Kalinowski, Carlos E. Milla, Paul L. Bollyky

Summary: This study investigates the inhibitory effect of the oral drug hymecromone on hyaluronan (HA) synthesis in humans. The results demonstrate a significant reduction in sputum HA levels after oral hymecromone treatment in healthy individuals, suggesting its potential in the treatment of pulmonary diseases related to HA.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Meeting Abstract Respiratory System

The filamentous Pseudomonas phage Pf disrupts airway basal cell proliferation

Elizabeth Burgener, Laura Rojas Hernandez, Paul Bollyky, Carlos Milla

EUROPEAN RESPIRATORY JOURNAL (2021)

暂无数据